Renal Transplant Rejection: Clinical Trials

37 trials for Renal Transplant Rejection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 6 unknown, 5 terminated, 2 recruiting. 12 Phase 4, 7 Phase 2, 6 Phase 1, 5 Not applicable, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 412Completed 9, Terminated 2, Unknown 1
Phase 27Completed 3, Active not recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 16Unknown 2, Active not recruiting 1, Completed 1, Recruiting 1, Withdrawn 1
Not applicable5Completed 5
Phase 33Terminated 2, Recruiting 1

Follow Renal Transplant Rejection: new trials by email Literature Review of Renal Transplant Rejection trials Research Report on Renal Transplant Rejection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multi-Parametric MRI for Renal Transplantation
Magnetic Resonance Imaging - Renal Transplant Rejection
Not yet recruitingUniversity of Minnesota1402027-07-012026-09-16
Deep Phenotyping of the Renal Allograft to Prognosticate Clinical Outcomes
Renal Transplant Rejection
WithdrawnUniversity of Pittsburgh2026-04-012026-11-05
Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
Rabbit Anti thymocyte globulin (rATG), Basiliximab - Renal Transplant Rejection, Induction Therapy
Phase 3RecruitingUniversity Hospital, Tours2442023-11-072026-06-18
NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation
Tacrolimus - Renal Transplant Rejection, Renal Transplant Infection
Phase 1 / Phase 2WithdrawnUniversity College, London2023-02-202023-05-11
Torque Teno Virus: A Biomarker of Immunosuppression
None Observational study - Renal Transplant Rejection, Immunosuppression
CompletedQueen Mary University of London2682022-02-152026-02-23
Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant
BIC/F/TAF 50Mg-200Mg-25Mg Tablet - HIV Infections, Renal Transplant Rejection
Phase 4CompletedWeill Medical College of Cornell University202020-11-092025-08-12
Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Donor CD34+ and CD3+ cells - Renal Transplant Rejection, Tolerance
Phase 1 / Phase 2RecruitingJeffrey Veale, MD152019-11-062026-05-08
Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection
Fostamatinib - Renal Transplant Rejection
Phase 1 / Phase 2Active not recruitingImperial College London82019-05-082024-11-25
Heme Arginate in Transplantation Study
Heme Arginate 25 MG/ML, 0.9% Sodium-chloride - Renal Transplant Rejection, Renal Transplant Failure
Phase 3TerminatedUniversity of Edinburgh472019-03-122025-11-17
Pathology and Imaging in Kidney Allografts
Multi-parametric renal MRI - Renal Transplant Rejection, Chronic Kidney Diseases
TerminatedNHS Greater Glasgow and Clyde292019-02-152022-06-03
Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation
Tacrolimus Extended Release Oral Tablet, Tacrolimus - Renal Transplant Rejection, Kidney Transplant Failure and Rejection
Phase 4CompletedColumbia University502018-07-262024-07-17
Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection
Sonazoid, contrast enhanced ultrasonography - Renal Transplant Rejection
Phase 2CompletedBrigham and Women's Hospital82018-05-302023-03-06
Dose Adjustment of Tacrolimus Based on Home Sampling in Renal Transplant Recipients
Micro sampling - Renal Transplant Rejection
CompletedOslo University Hospital272018-04-042019-08-28
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients
Prograf, Tacrolimus - Renal Transplant Rejection
Phase 4CompletedUniversity of California, Los Angeles1762018-03-012023-04-28
Urine CXCL10 Chemokine Monitoring Post-renal Transplant
Rejection treatment according to clinical standard-of-care - Renal Transplant Rejection
Not applicableCompletedUniversity Hospital, Basel, Switzerland2412017-09-282022-08-11
VIRTUUS Children's Study
Renal Transplant Rejection, Pediatric Kidney Disease
CompletedChildren's Hospital of Philadelphia4452017-08-102026-07-06
ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation
Mixed lymphocyte reaction - Renal Transplant Rejection, Immune Repertoire
UnknownMedical University of Vienna502017-07-012023-10-23
MRI in Renal Transplantation
Magnetic resonance imaging - End Stage Renal Disease, Renal Transplant Rejection
UnknownNHS Greater Glasgow and Clyde202017-04-112018-10-15
Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)
Antithymocyte Immunoglobulin (Rabbit) - Renal Transplant Rejection
Phase 2CompletedProf. Dr. Petra Reinke682016-12-152021-01-29
A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death
mesenchymal stem cell - Disorder Related to Renal Transplantation, Renal Transplant Rejection
Phase 1UnknownQipeng Sun2602016-01-012015-07-03

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Rejection, Psychology (5)  ·  Kidney Failure, Chronic (3)  ·  Fibrosis (2)  ·  Renal Insufficiency, Chronic (2)  ·  Delayed Graft Function (1)  ·  HIV Infections (1)  ·  HIV Seropositivity (1)  ·  Kidney Diseases (1)

Broader conditions

Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Behavior (5)  ·  Social Behavior (5)  ·  Urogenital Diseases (5)  ·  Chronic Disease (4)  ·  Disease Attributes (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Male Urogenital Diseases (4)  ·  Renal Insufficiency (4)  ·  Urologic Diseases (4)  ·  Kidney Diseases (3)  ·  Renal Insufficiency, Chronic (2)  ·  Blood-Borne Infections (1)

Interventions

Tacrolimus (5)  ·  Antilymphocyte Serum (3)  ·  Mycophenolic Acid (3)  ·  Basiliximab (2)  ·  Everolimus (2)  ·  Magnetic Resonance Imaging (2)  ·  Rituximab (2)  ·  Abatacept (1)  ·  Adrenal Cortex Hormones (1)  ·  Blood Specimen Collection (1)  ·  Bortezomib (1)  ·  Control Groups (1)  ·  Cyclosporine (1)  ·  Demography (1)  ·  Drugs, Generic (1)

Sponsors

NHS Greater Glasgow and Clyde (2)  ·  University of California, Los Angeles (2)  ·  Andre Barreto Pereira (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Brigham and Women's Hospital (1)  ·  Children's Hospital of Philadelphia (1)  ·  Columbia University (1)  ·  E. Steve Woodle (1)  ·  Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1)  ·  Fuzhou General Hospital (1)  ·  Imperial College London (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  Jeffrey Veale, MD (1)  ·  Leiden University Medical Center (1)  ·  Loma Linda University (1)

Countries

United States (15)  ·  United Kingdom (5)  ·  France (3)  ·  Brazil (2)  ·  Spain (2)  ·  Austria (1)  ·  Canada (1)  ·  China (1)  ·  Germany (1)  ·  India (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Portugal (1)  ·  Switzerland (1)

Top investigators

E. Steve Woodle, MD (2)  ·  Adele Rike, PharmD (1)  ·  Alastair J Rankin, MBChB (1)  ·  Andre B Pereira, PhD (1)  ·  Aravind Cherukuri, MD (1)  ·  Aruna Rakha, PhD. (1)  ·  Brendan Keating, DPhil (1)  ·  Catherine B Small, MD (1)  ·  Domingo Hernandez, PhD (1)  ·  Elias David-Neto, PhD (1)  ·  Flavio Vincenti, M.D. (1)  ·  Frederick Tam, MBBChir (1)  ·  Heike E Daldrup-Link, MD, PhD (1)  ·  Jeffrey Veale, MD (1)  ·  Jianming Tan, M.D and Ph.D (1)

Results publications

PMID 11045649, PMID 15192134, PMID 22081892, PMID 22436957, PMID 23009139, PMID 23349326, PMID 25386950, PMID 25491391, PMID 29145879, PMID 29514693, PMID 30229398, PMID 30903722, PMID 31335773, PMID 31477052, PMID 32775820, PMID 33947168, PMID 34067039, PMID 34721420, PMID 36094829, PMID 36644348, PMID 37228005, PMID 37426430, PMID 37525369, PMID 39147695, PMID 39372414, PMID 39382091, PMID 40374867

NIH funding

2018 (1), R01HD091185 (1)